MedPath

A COMPARATIVE STUDY OF INTRANASAL DEXMEDETOMIDINE AND INTRANASAL MIDAZOLAM FOR PREMEDICATION IN CHILDREN POSTED FOR TONSILLECTOMY

Not Applicable
Completed
Conditions
Health Condition 1: null- Children of age 6 to 12 yrs of ASA physical status 1 undergoing elective tonsillectoy.
Registration Number
CTRI/2021/07/034831
Lead Sponsor
Sri Manakula Vinayagar Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Undergoing Elective Tonsillectomy

ASA physical status I

Exclusion Criteria

1.Recent upper respiratory tract infection/lower respiratory tract infection

2.Known allergy or Hypersensitivity reaction to dexmedetomidine or midazolam.

3.Renal and Hepatic failure

4.Leukaemia

5.Cardiac arrthymias

6.Congenital diseases

7.DEvelopmental delay.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the effect of intranasal Dexmedetomidine 1mcg/kg and Intranasal Midazolam 0.2mg/kg administered one hour before induction to asses hemodynamics,sedation,co-operation for mask induction,anxiety levelTimepoint: Hemodynamic-0 min to 120 min and sedation,co-operation for mask induction,anxiety level asses 0 min to 70 min.
Secondary Outcome Measures
NameTimeMethod
Childs acceptance of intranasal drugs <br/ ><br>Incidence of side effectTimepoint: when premedication is administered <br/ ><br>throughout the procedure and upto 1 hours after the end of procedure
© Copyright 2025. All Rights Reserved by MedPath